Harvard Bioscience(HBIO) - 2022 Q4 - Earnings Call Presentation

Enabling discovery, safety and production of tomorrow's therapeutics NASDAQ: HBIO Q4'22 Earnings Presentation Jim Green, Chairman, President & CEO Jennifer Cote, Interim CFO March 9, 2023 Forward-Looking Statements and Non-GAAP Financial Information Forward-Looking Statements Information in this presentation or in oral statements of the management of the Company may include forward-looking statements within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of ...